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Abstract
Background and Objectives
Neural blockade techniques are associated with a risk of acute cardiac toxicity after accidental intravenous (IV) injection of local
anesthetics (LAs). The aim of this study was to compare electrocardiographic (ECG) and hemodynamic (HEM) effects induced by IV
infusion of LAs in an anesthetized ewe model.
Methods
Thirty-two anesthetized ewes received IV bupivacaine (BUPI), ropivacaine (ROPI), or levobupivacaine (S-BUPI) at an equimolar
dose, or lidocaine (LIDO) at a three fold higher rate (n 8 in each group). Intervals RR, PR, QRS, QT, corrected QT (QT ), changes= c 
in systolic and diastolic arterial pressure ( SAP and DAP) and in myocardial contractility ( dP/dt), were assessed every 30 secondsΔ Δ Δ
for 7 min. From main ECG variables (RR, PR, QRS, QT), we proposed to use multiple correspondence analysis (MCA) and
hierarchical ascending classification (HAC) to explore the structure of statistical dependencies among those measurements, and to
determine the different patterns of ECG and HEM changes induced by infusion of BUPI, ROPI, S-BUPI and LIDO.
Results
Graphic representation of MCA associated BUPI with the most pronounced modifications in ECG and HEM variables, followed in
decreasing order by ROPI, S-BUPI, LIDO. Comparisons of clusters identified by HAC confirmed this classification for ECG
variables. Ventricular tachycardia occurred only in BUPI group.
Conclusion
In our anesthetized ewe model, high dose IV infusion of BUPI induced the most marked changes in RR, PR, QRS, QT, QT intervals, C 
SAP and dP/dt. ROPI altered ECG variables less than BUPI but more than S-BUPI. LIDO was associated with the smallestΔ Δ
changes.
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Introduction
The descriptions of several cardiac arrests following an accidental intra-venous (IV) injection of bupivacaine during peripheral nerve
blockade or epidural anesthesia ( ) have led to the development of new compounds, such as ropivacaine and levobupivacaine.1 
The greater security provided by these single S-enantiomers compared with bupivacaine is supported by several studies, on isolated
heart ( ), awake or anesthetized animals ( ). Higher IV doses of ropivacaine and levobupivacaine than racemic bupivacaine are2 3 –5 
required to induce central nervous system (CNS) effects and cardiovascular (CV) disturbances (impairment of atrio-ventricular conduction,
decreased myocardial contractility) ( ). Nevertheless descriptions of cardiovascular accidents with ropivacaine ( ) and3 –5 6 
levobupivacaine ( ) compels to keep in mind the remaining narrow safety margin of these drugs.7 
Studies on healthy volunteers are limited by the necessarily low doses of local anesthetics (LAs) administrated IV ( ), markedly lower8 
than doses used in clinical practice for neuraxial blockade. Therefore assessment of cardiovascular effects of LAs requires animal models.
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An anesthetized animal model decreases the overlap between neurologic and cardiovascular toxicity, as the latter is increased by hypoxia,
hypercarbia and acidosis related to convulsions primarily occuring in awake animals ( ).9 
The aim of this study was to describe and compare electrocardiographic and hemodynamic effects induced by high doses of LAs
(bupivacaine, ropivacaine, levobupivacaine and lidocaine) administrated IV in an anesthetized ewe model.
Materials and Methods
The study was performed according to a protocol approved by the Local Committee of Laboratory Investigation and Animal Care of
our institution and achieved in accordance with the rules and guidelines concerning the care and the use for laboratory animal experiments
(agreement n  B35-238-21). Experiments were performed on 32 non-pregnant Lacaune ewes (mean weight: 57 kg, range 48 74 kg) which° –
were obtained from INRA (Saint Gilles, France, authorization number Fr 35 240 046).
Animal preparation
Ewes were anesthetized with an IV injection of thiopental (5 8 mg/kg) through a catheter inserted in the right jugular vein. Animals–
were intubated, and ventilation was controlled mechanically (end-tidal CO2 35 mmHg). Throughout the experiment, anesthesia was
maintained with isoflurane 1.5  in oxygen/air (50 /50 ). Isoflurane coud be transciently increased to a maximum of 2  or decreased to% % % %
a minimum of 1 in case of movements or progressive decrease in blood pressure respectively. Another catheter was inserted in the left%
jugular vein for blood sampling, and administration of maintenance fluid. A standard electrocardiogram (ECG) was continuously recorded,
and arterial blood pressure was monitored invasively through a 20 G radial arterial catheter (Leader Cath-Vygon). A simplified
electroencephalogram (EEG) (two parietal and two occipital electrodes) was also recorded in order to detect any convulsive pattern. Body
temperature was checked by an oesophageal thermistor, and a heat lamp was used to maintain body temperature above 37.5 C. IV°
administration of LAs was performed when hemodynamic parameters were stabilized, after at least one hour of general anesthesia.
Local anesthetic experiments
In a preliminary study, the dose of ropivacaine hydrochloride needed to obtain a cardiac arrest after an IV administration of six
minutes had been determined at 1.43 mg/kg/min.
The first group of ewes was administered IV ropivacaine hydrochloride (HCl) (ROPI, n 8) at the dose determined above, over 6=
minutes. Bupivacaine (BUPI, n 8) and levobupivacaine (S-BUPI, n 8) groups were administered an equimolar dose of the respective LAs= =
Hcl over 6 minutes (1.49 mg/kg/min or 4.58 mol/kg/min). The last group received lidocaine (HCl) (LIDO, n 8) at a three fold equimolarμ =
rate (3.74 mg/kg/min or 13.77 mol/kg/min over 6 minutes) in order to respect the potency of LAs ( ). The mean doses were 502 mg,μ 10 
(range 412 635 mg) for the ROPI, BUPI and S-BUPI groups and 1393 mg (range 1235 1544 mg) for the LIDO group.– –
Plasma concentrations of LAs were determined every minute using High Performance Liquid Chromatography (HPLC). Blood
samples were collected in 4.5 ml under vacuum vials containing 0.054 ml of a 15  K3E anticoagulant solution (Vacutainer TM, Becton%
Dickinson, Plymouth, UK). After centrifugation at 3500  G for 10 min, plasma was stored in polyethylene tubes at 20 C until analysis.× − °
Ropivacaine, bupivacaine, levobupivacaine and lidocaine were extracted from plasma according to a previously published method with
slight modifications ( ). Briefly, 0.5 ml of plasma sample were alkalinized by 50 l of 1 M NaOH and 3 ml of n-Heptane were added,11 μ
after horizontal shaking (3 min) and centrifugation (3 min at 3500 g), the organic phase was transferred to a conical vial containing 50 lμ
of 0.05 M H2SO4. After similar shaking and centrifugation, the organic phase was discarded, and the aqueous phase was buffered with 10 
L of 0.5M K2HPO4 and 40 L were injected onto the chromatographic system. The chromatographic system consisted in a Milton Royμ μ
model spectromonitor-3 UV detector (LDC Milton Roy, Riviera Beach, FL, USA), a Waters Model pump, a Waters Model 717 automatic
injector and a Waters Empower-Pro data acquisition system (Waters Assoc., Milford, MA, USA). The analytical chromatographic column
was a Lichrocat-Lichrospher RP-B Merck cartridge (length 125 mm, internal diameter 3 mm). The flow rate was 0.5 ml/min, and the
temperature was maintained at 30 C. The mobile phase consisted of a mixture of acetonitrile (23 ) and a 10 mM sodium° %
dihydrogenphosphate and 8.7 mM orthophosphoric acid aqueous solution, pH 2.1 (77 ).%
Electrocardiographic and hemodynamic measurements
ECG, invasive arterial pressure (systolic arterial pressure (SAP), and diastolic arterial pressure (DAP)), and EEG were obtained
continuously and recorded on a personal computer with Chart (Chart 5.0 software, AD Instruments, Castle Hill, NSW, Australia), and
sampled at 400 Hz. ECG variables:RR, PR, QRS, QT intervals (ms), corrected QT using Bazett s formula (QT  QTXRR , ms), and’ C = 0,5 −
hemodynamic variables (HEM): SAP and DAP (mmHg) and dP/dt (maximum rate of rise in arterial pressure, mmHg/ms), reflecting the
myocardial contractility, were assessed one minute before (T0 60 sec, baseline data) and every 30 seconds during seven minutes (last–
measurement: T0 420sec) following the beginning of IV injection (T0). Changes in HEM variables compared to baseline were determined+
at each time point ( SAP, DAP, dP/dt). Onsets of asystoly, electromechanical dissociation, ventricular tachycardia or fibrillation wereΔ Δ Δ
also noted for each ewe.
Reg Anesth Pain Med . Author manuscript
Page /3 11
Statistical analysis
The objective of this analysis was to describe ECG and HEM changes over time after IV infusion of four different LAs in anesthetized
ewes.
Main variables of this analysis were RR, PR, QRS, and QT intervals measured on ECG at each time of the procedure. In order to
establish the underlying structure between these variables, relations between them were calculated and visualised on a graph, using
Multiple Correspondence Analysis (MCA) ( ). On the model obtained, secondary variables were showed, such as the type of LA12 
infused, times of the procedure, and other ECG and HEM variables (corrected QT, SAP, DAP, dP/dt).Δ Δ Δ
The interpretation of the analysis was then enriched by identification of different clusters of ewes, using Hierarchical Ascending
Classification (HAC) ( ).13 
MCA and HAC allowed this methodological approach, while respecting the relationships between analysed variables, wether they
were linear or not.
Multiple Correspondence Analysis and Hierarchical Ascending Classification
Homogenization of variables
First of all, a classification of continuous variables according to the fuzzy coding method was performed ( ). In this method, each14 
variable was segmented according to its quartile values. Then, for each constituted class of principal ECG variables, a new class was
created by overlapping two contiguous classes. This permited the retention of the same numbers in each class and preserved the notion of
distribution around the median.
Generation of the contingency table
MCA relies on the analysis of a contingency table, where each element describes the number of observed individuals partitioned
among the modalities of qualitative variables. In our study, the qualitative variables were the four principal ECG variables (RR, PR, QRS,
QT), coded following the method described above.
Basics of MCA estimates
From the contingency table obtained, MCA estimated relationships between distribution profiles. Similarities between profiles were
taken into account by using a metric. The distance is a well known similarity measure of statistical dependence between qualitativeχ2 χ2 
variables. Such metric made it possible to compare shapes of distribution profiles, providing an analysis of the underlying structure of
statistical dependencies among ECG variables. ECG variables were represented by their projections on the first principal components (i.e.
axis 1 and 2).
On this graph were then showed secondary variables: type of LA infused, times of the procedure, corrected QT, and changes in HEM
variables ( SAP, DAP, dP/dt). To help interpretation, barycentre (center of mass) of each group of ewes (BUPI, ROPI, S-BUPI, LIDO)Δ Δ Δ
was projected on the two first principal components (axis 1 and 2).
HAC
HAC was applied on MCA principal components to extract groups of ECG variables considered as neighbours. A classification tree of
neighbour points was obtained (dendogram). These clusters were then analyzed for each variable studied (main and secondary variables) in
term of the positions of each cluster on the structured model, using Mann-Whitney U test, because the variables studied did not have a
normal distribution.
All statistical analyses were performed with the BI  LOGINSERM 1979/1987 software. Statistical results were considered significant©
when p<0.05.
Results
Among the four groups of ewes, there was no significant difference either in weight or in baseline data (T0 60 sec) for ECG and HEM–
variables ( ).table 1 
No convulsive pattern was observed on EEG during and after IV infusion of LAs.
Multiple Correspondence Analysis
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Projection of the main variables on the first two principal components is shown on . Analysis of structure provided by MCAfigure 1a 
from principal variables (RR, PR, QRS, QT) showed a distribution following the axis one. Low values of principal variables were
observed on the right of the graph (RR1, PR1, QRS1, QT1), and high values on the left (RR7, etc.).
The same disposition was observed for secondary variables (QT , SAP, DAP, dP/dt), with low values on the right (QT 1, C Δ Δ Δ C Δ
SAP1, DAP1, dP/dt1) and high values on the left (QT 4, etc.) ( ).Δ Δ C figure 2 
Barycentres (centers of mass) of each group of LA were determined and followed globally the horizontal axis (axis 1) with
respectively from right to left: LIDO, S-BUPI, ROPI and BUPI ( ). Barycentres of each time point of the procedure were alsofigure 1b 
following the axis one, with baseline and early sequences on the right, and late sequences on the left (T0 90sec to T0 420sec) (+ + figure 1b 
and ).2 
Therefore MCA established a link between the drug infused and ECG and HEM changes. The smallest alterations of RR, PR, QRS,
QT, QT intervals, changes in SAP, DAP and changes in myocardial contractility were associated with the LIDO group, followed inC 
increasing alterations order by S-BUPI, ROPI, and BUPI groups.
Hierarchical Ascending Classification
HAC identified 6 clusters in the correspondence analysis ( , top). Clusters 1 and 2 were characterized by their prominence infigure 3 
high values of ECG variables and HEM changes compared to clusters 3 to 6 ( , bottom: dendogram). Dots from cluster 1 mainlyfigure 3 
originated in the BUPI group and showed the highest values for ECG variables and HEM changes compared to other subsets (p<0.05) (
). The lowest values and changes were in cluster 6 (p<0.05), coming mainly from the LIDO group. Dots from cluster 2 stemmedfigure 4 
mainly from the ROPI group, with lower ECG and HEM alterations than in cluster 1 (p<0.05) and more pronounced alterations than in
clusters 3 (except for QRS interval), 5 and 6. S-BUPI was widely present in cluster 3, although not prominent; in the latter, ECG changes
were lower than in cluster 2 (p<0.05), conversely there was no significant changes in HEM parameters compared to cluster 2 ( ).figure 4 
Mortality was not different between BUPI, ROPI and S-BUPI groups. Although a three fold higher infusion was used in the LIDO
group, seven of eight ewes survived. Ventricular tachycardia occurred in three ewes from the BUPI group, but was not seen in ROPI and
S-BUPI groups. Abrupt onset of asystoly was observed in respectively two and four of eight ewes in BUPI and ROPI groups, and
electromechanical dissociation was the first impairment observed in respectively two, three and eight of eight ewes in the BUPI, ROPI and
S-BUPI groups. Ventricular tachycardia, asystoly or electromechanical dissociation occurred 2 min or more after the end of IV infusion in
ROPI, S-BUPI and LIDO groups. Conversely, in BUPI groups, severe dysrythmias occurred before the end of IV infusion in 3 of 8 ewes.
Plasma concentrations
Plasma concentrations of LA ( g/ml) reflected ECG and HEM alterations ( ). Concentrations of BUPI, ROPI and S-BUPI wereμ figure 5 
homogeneous during the first 4 minutes following the beginning of IV infusion. Conversely, a large inter-individual variation was
observed after the 4 minute, especially in the S-BUPI and LIDO groups.th 
Discussion
The main findings of this study are 1) the less pronounced ECG and HEM alterations induced by single S-enantiomers compared to
racemic bupivacaine, 2) the unexpectedly less marked ECG alterations induced by levobupivacaine compared to ropivacaine, 3) the slight
alterations induced by lidocaine despite the high dose infused.
To our knowledge this is the first study of the effects of IV infusion of LAs on an anesthetized ewe model. Although far from
situations that can be met in clinical practice, our model and the statistical method used allows us to obtain patterns of ECG and HEM
changes over time induced by high doses IV LAs infusion. Studies conducted on conscious sheep, a better model for simulation of an
accidental IV injection of LA, are not able to describe fully the cardiovascular effects because of primary induced CNS effects ( ). Onset15 
of convulsions results in tachycardia and hypertension and precludes further assessment of CV alterations induced directly by LAs. Direct
left intra-coronary infusion of increasing doses of LAs avoids this overlap between CNS and CV effects but cuts off the model from
arythmogenic effects of LAs ( ).16 
A significantly less impairment of RR, PR, QRS, QT and QT intervals, and of blood pressure and myocardial contractility wasC 
observed in ROPI and S-BUPI groups compared with BUPI group, in agreement with other studies conducted on different models ( , ,2 4 17
). Even though high doses of IV LAs were infused in our study, ventricular tachycardia occurred only in BUPI group, before the end of the
six-minutes IV infusion (3 of eight ewes). Ventricular dysrhythmias were also more frequently observed with bupivacaine when compared
to levobupivacaine ( ) or to ropivacaine ( ). In our study, the occurrence of such ventricular arythmias may have been decreased by17 18 
interactions between isoflurane used to maintain general anesthesia and LAs, at least in BUPI group ( ).19 
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An unexpected result is the lower impairment of ECG variables induced by levobupivacaine compared to ropivacaine. The barycentre
position of the S-BUPI group appears unquestionably between the LIDO and ROPI groups on the graphical representation of MCA (
and ). Nevertheless, even though a large proportion of dots in cluster 3 identified by HAC originates in S-BUPI group,figures 1b 2b 
numerous dots from LIDO group contribute also to this cluster. Therefore direct comparison of cluster 3 with others does not allow firm
conclusions. To better understand the alterations observed in our model, we performed a crossed analysis between time, LAs, and clusters
identified by HAC. Times of the procedure were divided into four parts (T1: baseline, T2: T0 30 to T0 90sec, T3: T0 120 to T0 240sec,+ + + +
T4: T0 270 to T0 420sec, with T0: beginning of IV infusion), and we looked at the distribution of ewes according to LAs infused and+ +
clusters ( ). The major observation was that clusters 1 and 2 contain respectively 51.8  and 50.0  of ewes from BUPI and ROPItable 2 % %
groups at late periods of the experiment (T3 T4 periods), against only 25.0  of ewes from S-BUPI group. Considering the prominence of+ %
high alterations in ECG variables in clusters 1 and 2 compared to other clusters ( , bottom: dendogram), this cross analysisfigure 3 
confirms the lower impairment of ECG variables by S-BUPI compared to BUPI and ROPI in our study. Conversely HEM changes induced
by S-BUPI are not significantly different from those induced by ROPI ( , clusters 2 and 3).figure 4 
Similar doses of levobupivacaine and ropivacaine are required to induce a cardiac arrest ( ), although numerous studies document16 
intermediate cardiovascular effects of levobupivacaine, between bupivacaine and ropivacaine. On an isolated rabbit heart model, Mazoit
and collaborators ( ) reported an increase in QRS duration in the respective ratio of 1:0.4:0.3 for racemic bupivacaine, levobupivacaine2 
and ropivacaine respectively. In a rat model, Ohmura and collaborators ( ) observed that the cumulative doses of bupivacaine,20 
levobupivacaine and ropivacaine necessary to induce dysrythmia were respectively 1:3.3:6.9. This discrepancy between our study and
others could be explained partly by the higher lipophilicity of levobupivacaine compared to ropivacaine, resulting in a higher pulmonary
uptake ( ). This larger pulmonary uptake observed by Ohmura and co-workers in anesthetized rabbits was associated with a lower21 
maximal plasma level of levobupivacaine compared to ropivacaine. Nevertheless this was not observed in our study, where plasma level
were relatively similar and homogeneous during the first 4 minutes of IV infusion ( ).figure 5 
Another surprising result is the proximity between barycentres of ROPI and BUPI groups observed after MCA. A more pronounced
difference between these 2 drugs was expected, even if comparisons of clusters 1 (mainly originating in BUPI group) and 2 (mainly
originating in ROPI group) confirms a significantly lower impairment of ECG and HEM parameters induced by ropivacaine compared to
bupivacaine. Proximity of these two barycentres in MCA is explained by analysis of cluster 4: indeed dots from this cluster originated
mainly in two ewes from BUPI group, whose ECG alterations were quite different from other ewes of the group: QRS and overall QT
increased only slightly over the course of IV infusion. Nevertheless RR, PR, and HEM changes were similar to changes reported in other
ewes from BUPI group, and plasma concentrations of BUPI were not different when compared with concentrations obtained in other ewes
of the same group. We had therefore no valuable reason to exclude these 2 ewes from analysis, even if this unexplained effect on QRS and
QT results in a deviation on the right of the BUPI barycentre, bringing it close to ROPI group.
Last, our study confirms that high doses of lidocaine are needed to induce ECG and HEM impairments, as observed by other authors.
Nine to sixteen times more lidocaine are needed to induce the same ECG alterations than bupivacaine ( , ). Furthermore, only 13.515 22 %
of dots from LIDO group are observed in clusters characterized by pronounced ECG alterations (clusters 1 and 2, ) during latetable 2 
periods of the experiment (T3 T4), compared to 25 , 50  and 51.8  for S-BUPI, ROPI and BUPI respectively. Only one ewe from+ % % %
LIDO group presented a severe cardiac consequence under the form of an electromechanical dissociation. Occurrence of ventricular
tachycardia with IV lidocaine appears to be rare: none was observed in the studies from Nancarrow and collaborators ( ) similarly to what3 
we found in our anesthetized ewe model.
Limitation of the study
In our study, decision was made to infuse equimolar doses of BUPI, ROPI and S-BUPI. If equipotency between BUPI and S-BUPI is
admitted ( ), this is not the case for ROPI and BUPI: Polley and collaborators observed that 40 to 50  more ropivacaine was needed to23 %
obtain the same efficacy than bupivacaine when administered epidurally ( ). Nevertheless for peripheral blockade, the least potency of24 
ROPI compared with BUPI remains to be demonstrated: for example, duration of anesthesia and analgesia were similar in axillary and
interscalenic blocks ( , ). Those controversial data lead us to keep equimolar infusions. Increasing the doses of ROPI infused would25 26 
have likely conducted to more severe impariments of ECG and HEM variables, which would have even enhanced the difference between
S-BUPI and ROPI.
Our choice of a 6-min IV infusion under general anaesthesia in ewes has several limitations. First this is not a frequent situation in
clinical practice, as continuous perineural infusion is performed with much lower doses than those administered IV in our study. Second,
general anaesthesia, especially with inhaled anaesthetics such as isoflurane, can modify the cardiovascular response to LA IV infusion
directly through vasodilation and negative inotropic effect, and eventually indirectly through CNS-induced cardiovascular effects.
Nevertheless this model provided a reduced overlap between CNS and cardiovascular system as illustrated by the absence of convulsions,
and allows a more complete assessment of ECG and HEM changes than in awake animals.
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In conclusion, ECG and HEM alterations induced by equimolar IV infusion of BUPI, ROPI and S-BUPI are more pronounced in the
BUPI group than in the ROPI and S-BUPI groups. Furthermore, in our anesthetized ewe model, S-BUPI seems to modify ECG variables
less than ROPI does, while HEM changes are similar in those two groups. Despite a three times higher dose infused, LIDO is associated
with the smallest impairments in ECG and HEM variables.
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Figure 1
Figure 1a. Ewes were disposed according to the level of resemblance of their ECG variables (RR, PR, QRS, QT) in the multidimensional
space of the Multiple Correspondance Analysis using values of the four principal ECG parameters (RR, PR, QRS, QT) measured at each time
of the procedure (from T0-60sec to T0 420sec, i.e. 14 points per ewe). ECG variables were globally following axis 1. Low values were on the+
right (parameters with number 1: RR1, QRS1 ), high values on the left (parameters with number 7). … Figure 1b. The barycentre of each group
of LAs (BUPI, ROPI, S-BUPI, LIDO, used as secondary variables) was then determined in the MCA. We could observe a distribution of
those barycentres along axis 1. Barycentres of successive time points of the procedure were also drawn on the graph. Time was also following
the axis 1, with baseline (T0-60sec) and early sequences of the procedure on the right, and later sequences on the left (T0 90sec to T0+ +
420sec).
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Figure 2
Graphic representation of MCA using LAs, time, QT , PAS, PAD, dP/dt as secondary variables. The distribution of HEM variables inC Δ Δ Δ
MCA was also following globally the axis 1. Low values were on the right (parameters with number 1), high values on the left (parameters
with number 4).
Figure 3
Figure 3, top. Clusters identified by Hierarchical Ascending Classification (1 to 6). Ewes disposed by MCA were allocated to homogeneous
subsets according to their level of resemblance considering principal ECG variables. 6 clusters were identified, whose composition is detailed
in . : cluster 1. : cluster 2. : cluster 3. : cluster 4. : cluster 5. : cluster 6. Figure 6 ■ □ ▲ * ○ ● Figure 3, bottom. Dendogram resulting from HAC.
Among the homogeneous clusters distinguished by HAC, a main caesura was evidenced between clusters 1 and 2 on one hand, with
pronounced alterations of principal ECG variables, and clusters 3 to 6 on the other hand, with less marked alterations (clusters 3 and 4:
intermediary alterations, clusters 5 and 6: moderate alterations).
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Figure 4
Comparisons of ECG and HEM variables between the 6 clusters identified by Hierarchical Ascending Classification. High values are on the
left, low values on the right. Significant differences between clusters regarding ECG and HEM variables are shown. For example, using a
Mann-Whitney test, the relationship established between RR interval and types of LAs infused was confirmed by the significant difference in
RR lenght between clusters 1, 2 and 4 (originating respectively mainly in ROPI and BUPI groups) and respectively cluster 3 (mixed subset
from LIDO and S-BUPI groups), and clusters 5 and 6 (originating mainly in LIDO group). 
: cluster or group of clusters significantly different (p<0.05) from others in term of each variable.
Figure 5
Plasma concentrations ( g/ml, mean SD) of bupivacaine ( ), ropivacaine ( ), Sbupivacaine ( ) and lidocaine ( ) measured each minuteμ ± □ ■ ○ △
during IV infusion (min 1 to min 6) and one minute after the end of infusion. n 8 in each group. n decreased progressively in BUPI group=
related to severe dysrythmias occurring before the end of IV infusion.
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Figure 6
Cross analysis between groups (BUPI, ROPI, S-BUPI, LIDO) and periods of the experiment: T1: baseline (T0-60sec), T2: T0 30sec to T0+ +
90sec, T3: T0 120sec to T0 240sec, T4: T0 270 to T0 420sec (T0: beginning of IV infusion).+ + + +
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Table 1
Weight (mean SD), ECG variables (RR, PR, QRS, QT, QTC: ms, mean SD) and hemodynamic variables (SAP and DAP: mmHg, mean SE, dP/dt: mmHg/ms, mean SD) before i.v. infusion of LAs in± ± ± ±



















BUPI 59.6 11.0± 617 87± 115 7± 59 14± 360 35± 464 60± 101 11± 79 13± 0.25 0.04±
ROPI 59.6 7.7± 641 151± 122 29± 54 15± 360 75± 449 56± 104 20± 79 21± 0.29 0.09±
SBUPI 56.0 4.0± 579 63± 105 11± 51 10± 343 39± 445 47± 104 19± 74 14± 0.25 0.13±
LIDO 54.1 4.4± 561 103± 106 22± 58 12± 339 39± 455 27± 97 14± 73 16± 0.23 0.10±
Table 2
Cross analysis between clusters identified by HAC, groups (BUPI, ROPI, S-BUPI, LIDO), and periods of the experiment: T0 T1: baseline to T0 90sec. T2 T3: T0 120 to T0 420sec. Data are exposed+ + + + +
in percentages of total number of dots for each group of LA. Subsets are grouped according to the dendogram provided by HAC (clusters1 2: severe alteration of ECG variables, clusters 3 4:+ +
intermediary alterations, clusters 5 6: moderate alterations).+
period Local Anaesthetic Clusters 1 2+ Clusters 3 4+ Clusters 5 6+
T1 T2+
ROPI 15.2% 1.8% 11.6%
BUPI 8.0% 7.0% 17.0%
S-BUPI 6.3% 3.6% 18.6%
LIDO 3.6% 0.9% 24.1%
T3 T4+
ROPI 51.8% 8.0% 11.6%
BUPI 50.0% 18.0% 0%
S-BUPI 25.0% 41.1% 5.4%
LIDO 13.4% 35.7% 22.3%
